MiR-214 and N-ras regulatory loop suppresses rhabdomyosarcoma cell growth and xenograft tumorigenesis

Oncotarget

Volumn 5, Issue 8, 2014, Pages 2161-2175

  Huang, Hui jie ^a   Liu, Jun ^a   Hua, Hu ^a   Li, San en ^a   Zhao, Jin ^b   Yue, Shen ^a   Yu, Ting ting ^a   Jin, Yu cui ^a   Cheng, Steven Y ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

miR 214; N ras; RD cells; Rhabdomyosarcoma; Tumor suppressor

Indexed keywords

COMPLEMENTARY DNA; MICRORNA; MICRORNA 214; GUANOSINE TRIPHOSPHATASE; MEMBRANE PROTEIN; MIRN214 MICRORNA, HUMAN; NRAS PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER TISSUE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; GENE EXPRESSION; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; N RAS GENE; NONHUMAN; PROTO ONCOGENE; RHABDOMYOSARCOMA; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; FLOW CYTOMETRY; GENE INACTIVATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; NUDE MOUSE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TUMOR CELL LINE; WESTERN BLOTTING; XENOGRAFT;

ANIMALS; APOPTOSIS; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CARCINOGENESIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; FLOW CYTOMETRY; GENE KNOCKOUT TECHNIQUES; GTP PHOSPHOHYDROLASES; HETEROGRAFTS; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; TRANSFECTION;

EID: 84899584262     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1855     Document Type: Article

References (47)

1. Hayes-Jordan A and Andrassy R. Rhabdomyosarcoma in children. Curr Opin Pediatr. 2009; 21(3):373-378.
2. Xia SJ, Pressey JG and Barr FG. Molecular pathogenesis of rhabdomyosarcoma. Cancer Biol Ther. 2002; 1(2):97-104.
3. Bahrami A and Folpe AL. Adult-type fibrosarcoma: A reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period. Am J Surg Pathol. 2010; 34(10):1504-1513.
4. Sorensen PH, Lynch JC, Qualman SJ, Tirabosco R, Lim JF, Maurer HM, Bridge JA, Crist WM, Triche TJ and Barr FG. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. J Clin Oncol. 2002; 20(11):2672-2679.
5. Keller C, Arenkiel BR, Coffin CM, El-Bardeesy N, DePinho RA and Capecchi MR. Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. Genes Dev. 2004; 18(21):2614- 2626.
6. Keller C and Capecchi MR. New genetic tactics to model alveolar rhabdomyosarcoma in the mouse. Cancer Res. 2005; 65(17):7530-7532.
7. Keller C, Hansen MS, Coffin CM and Capecchi MR. Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin. Genes Dev. 2004; 18(21):2608-2613.
8. Koufos A, Hansen MF, Copeland NG, Jenkins NA, Lampkin BC and Cavenee WK. Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism. Nature. 1985; 316(6026):330-334.
9. Visser M, Sijmons C, Bras J, Arceci RJ, Godfried M, Valentijn LJ, Voute PA and Baas F. Allelotype of pediatric rhabdomyosarcoma. Oncogene. 1997; 15(11):1309-1314.
10. Hahn H, Wojnowski L, Zimmer AM, Hall J, Miller G and Zimmer A. Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nat Med. 1998; 4(5):619-622.
11. Hatley ME, Tang W, Garcia MR, Finkelstein D, Millay DP, Liu N, Graff J, Galindo RL and Olson EN. A mouse model of rhabdomyosarcoma originating from the adipocyte lineage. Cancer Cell. 2012; 22(4):536-546.
12. Charytonowicz E, Cordon-Cardo C, Matushansky I and Ziman M. Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell? Cancer Lett. 2009; 279(2):126- 136.
13. Merlino G and Helman LJ. Rhabdomyosarcoma--working out the pathways. Oncogene. 1999; 18(38):5340-5348.
14. Nitzki F, Zibat A, Frommhold A, Schneider A, Schulz Schaeffer W, Braun T and Hahn H. Uncommitted precursor cells might contribute to increased incidence of embryonal rhabdomyosarcoma in heterozygous Patched1-mutant mice. Oncogene. 2011; 30(43):4428-4436.
15. Buckingham M, Bajard L, Chang T, Daubas P, Hadchouel J, Meilhac S, Montarras D, Rocancourt D and Relaix F. The formation of skeletal muscle: from somite to limb. J Anat. 2003; 202(1):59-68.
16. Tapscott SJ. The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development. 2005; 132(12):2685-2695.
17. van Rooij E, Liu N and Olson EN. MicroRNAs flex their muscles. Trends Genet. 2008; 24(4):159-166.
18. Williams AH, Liu N, van Rooij E and Olson EN. MicroRNA control of muscle development and disease. Curr Opin Cell Biol. 2009; 21(3):461-469.
19. Ge Y and Chen J. MicroRNAs in skeletal myogenesis. Cell Cycle. 2011; 10(3):441-448.
20. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL and Wang DZ. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet. 2006; 38(2):228-233.
21. van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, Richardson JA, Kelm RJ, Jr. and Olson EN. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell. 2009; 17(5):662-673.
22. Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J, Cheng A, Hall BM, Qualman SJ, Chandler DS, Croce CM and Guttridge DC. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell. 2008; 14(5):369-381.
23. Naguibneva I, Ameyar-Zazoua M, Polesskaya A, Ait-Si- Ali S, Groisman R, Souidi M, Cuvellier S and Harel-Bellan A. The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat Cell Biol. 2006; 8(3):278-284.
24. Mendell JT and Olson EN. MicroRNAs in stress signaling and human disease. Cell. 2012; 148(6):1172-1187.
25. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009; 10(10):704-714.
26. Rota R, Ciarapica R, Giordano A, Miele L and Locatelli F. MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality. Mol Cancer. 2011; 10:120.
27. Taulli R, Bersani F, Foglizzo V, Linari A, Vigna E, Ladanyi M, Tuschl T and Ponzetto C. The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J Clin Invest. 2009; 119(8):2366-2378.
28. Flynt AS, Li N, Thatcher EJ, Solnica-Krezel L and Patton JG. Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate. Nat Genet. 2007; 39(2):259-263.
29. Aurora AB, Mahmoud AI, Luo X, Johnson BA, van Rooij E, Matsuzaki S, Humphries KM, Hill JA, Bassel-Duby R, Sadek HA and Olson EN. MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca(2)(+) overload and cell death. J Clin Invest. 2012; 122(4):1222-1232.
30. Watanabe T, Sato T, Amano T, Kawamura Y, Kawamura N, Kawaguchi H, Yamashita N, Kurihara H and Nakaoka T. Dnm3os, a non-coding RNA, is required for normal growth and skeletal development in mice. Dev Dyn. 2008; 237(12):3738-3748.
31. Juan AH, Kumar RM, Marx JG, Young RA and Sartorelli V. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell. 2009; 36(1):61-74.
32. Black BL and Olson EN. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol. 1998; 14:167-196.
33. Liu J, Luo XJ, Xiong AW, Zhang ZD, Yue S, Zhu MS and Cheng SY. MicroRNA-214 promotes myogenic differentiation by facilitating exit from mitosis via downregulation of proto-oncogene N-ras. J Biol Chem. 2010; 285(34):26599-26607.
34. Stratton MR, Fisher C, Gusterson BA and Cooper CS. Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction. Cancer Res. 1989; 49(22):6324-6327.
35. Linardic CM and Counter CM. Genetic modeling of Rasinduced human rhabdomyosarcoma. Methods Enzymol. 2008; 438:419-427.
36. Langenau DM, Keefe MD, Storer NY, Guyon JR, Kutok JL, Le X, Goessling W, Neuberg DS, Kunkel LM and Zon LI. Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev. 2007; 21(11):1382-1395.
37. Yan Z, Choi S, Liu X, Zhang M, Schageman JJ, Lee SY, Hart R, Lin L, Thurmond FA and Williams RS. Highly coordinated gene regulation in mouse skeletal muscle regeneration. J Biol Chem. 2003; 278(10):8826-8836.
38. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA and Olson EN. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A. 2006; 103(48):18255-18260.
39. deAlmeida AC, van Oort RJ and Wehrens XH. Transverse aortic constriction in mice. J Vis Exp. 2010; (38).
40. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV and Cheng JQ. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 2008; 68(2):425-433.
41. Rao PK, Missiaglia E, Shields L, Hyde G, Yuan B, Shepherd CJ, Shipley J and Lodish HF. Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells. Faseb J. 2010; 24(9):3427-3437.
42. Stern P, Astrof S, Erkeland SJ, Schustak J, Sharp PA and Hynes RO. A system for Cre-regulated RNA interference in vivo. Proc Natl Acad Sci U S A. 2008; 105(37):13895-13900.
43. Croci S, Landuzzi L, Astolfi A, Nicoletti G, Rosolen A, Sartori F, Follo MY, Oliver N, De Giovanni C, Nanni P and Lollini PL. Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells. Cancer Res. 2004; 64(5):1730-1736.
44. Pigault C, Follenius-Wund A, Schmutz M, Freyssinet JM and Brisson A. Formation of two-dimensional arrays of annexin V on phosphatidylserine-containing liposomes. J Mol Biol. 1994; 236(1):199-208.
45. Guo K, Wang J, Andres V, Smith RC and Walsh K. MyoDinduced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol. 1995; 15(7):3823-3829.
46. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D and Lassar AB. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science. 1995; 267(5200):1018-1021.
47. Thomas M, Lieberman J and Lal A. Desperately seeking microRNA targets. Nat Struct Mol Biol. 2010; 17(10):1169-1174.